Available at: http://www.who.int/trade/glossary/story076/en/ Accessed on 9th april 2014 2

(1)

Gestione della segnalazione di un cluster di mortalità per neoplasie emolinfopoietiche Pagina 139 e sorveglianza epidemiologica nel territorio della Asl 11 di Empoli

BIBLIOGRAFIA

1. World Health Organization. Trade, foreign policy, diplomacy and health. Public Health.

[Online]. Available at: http://www.who.int/trade/glossary/story076/en/ Accessed on 9^th april 2014

2. Devoto G, Oli G. Il Devoto-Oli. Vocabolario della lingua italiana 2007. Le Monnier, 2006.

3. Jefferson T. Cattive acque. John Snow e la vera storia del colera a Londra. Roma, Il Pensiero Scientifico editore, 2008.

4. Beck-Saguè C, Jarvis WJ, Martone WJ. Outbreak investigation. Infect Control Hosp Epidemiol 1997; 18: 138-145.

5. Infezioni correlate all’assistenza sanitaria. Sorveglianza e controllo. Dossier 123/2006 a cura di Sarti F, Agenzia Sanitaria Regionale dell’Emilia-Romagna. Bologna, marzo 2006.

[Online] Available at: http://asr.regione.emilia-

romagna.it/wcm/asr/collana_dossier/archivio_dossier_1.htm Accessed on 15^th april 2014

6. Knox EG. Detection of clusters. In: Elliott P (ed). Methodology of enquiries into disease clustering. London: Small Area Health Statistics Unit; 1989. p 17-20.

7. CDC. Guidelines for investigating clusters of health events. MMWR 1990;39[No. RR-11].

8. Gee A. Californian autism clusters leave researchers baffled. Lancet 2010; 376: 1451 – 1452.

9. Schiffer RB, McDemott MP, Copley C. A multiple sclerosis cluster associated with a small, north-central Illinois community. Arch Environ Health 2001; 56: 389-395.

10. Hawton K, Niedzwiedz C, Platt S. Suicide clusters: a review of risk factors and mechanisms. Suicide Life Threat Behav 2013; 43: 97-108.

11. Caller TA et al.Spatial clustering of amyotrophic lateral sclerosis and the potential role of BMAA. Amyotroph Lateral Scler 2012; 13: 25-32.

12. Wiemels J. Perspectives on the Causes of Childhood Leukemia. Chem Biol Interact 2012;

196: 59-67.

13. Trumbo CW. Public Requests for cancer cluster investigations: a survey of state health departments. Am J Public Health 2000; 90: 1300-2.

(2)

14. CDC. Investigating Suspected Cancer Clusters and responding to Community Concerns.

Guidelines from CDC and the Council of State and Territorial Epidemiologists. MMWR Recomm Rep 2013 ;62(RR-08):1-24.

15. Maryland Department of Health and Mental Hygiene. Questions and Answers about Cancer Clusters. Maryland Cancer Registry, 2013. [Online] Available at:

http://phpa.dhmh.maryland.gov/cancer/Documents/Questions%20and%20Answers%20 About%20Cancer%20Clusters.pdf Accessed on 28^th march 2014.

16. AIRTUM, CCM, AIOM. I numeri del cancro in Italia 2013. Brescia, Intermedia Editore, 2013. [Online] Available at: http://www.registri-tumori.it/cms/it/node/2888 Accessed on 4^th april 2014.

17. NCI (National Cancer Institute). NCI Fact Sheet: Cancer clusters. 2006 [Online] Available at: http://www.cancer.gov/cancertopics/factsheet/Risk/clusters. Accessed on 4^th april 2014.

18. Thacker. Time-space clusters: the public health dilemma. Health and environment digest 1989; 3(5):4-5.

19. Aldrich T et al. CLUSTER: user’s manual for software to assist with investigations of rare health events. Atlanta, Georgia: Agency for Toxic Substances and Disease Registries (ATSDR), 1990.

20. Agenzia Regionale per la Protezione Ambientale Toscana. Epidemiologia ambientale.

Metodi di studio e applicazioni in sanità pubblica. 2004, Firenze, ed. Litografia I.P.

Traduzione in lingua it. di Environmental Epidemiology. A Textbook on Study Methods and Public Health Applications, WHO 1999.

21. National Public Health Information Coalition and CDC. Cancer clusters: a toolkit for communicators. 2013. [Online] Available at: http://www.nphic.org/about/annual- report?task=cat_view&gid=256 Accessed 15^th april 2014.

22. Martinelli D, Mincuzzi A, Minerba S et al. Malignant cancer mortality in Province of Taranto (Italy). Geographic analysis in an area of high environmental risk. J Prev Med Hyg 2009; 50: 181-90.

23. Fazzo L, Tancioni V, Polichetti A et al. Morbidity experience in populations residentially exposed to 50 Hz magnetic fields: methodology and preliminary findings of a cohort study. Int J Occup Environ Health 2009; 15: 133-42.

(3)

24. Asl Milano. Rapporto su un cluster di leucemie infantili a Milano nel periodo dicembre

2009 – gennaio 2010. [Online] Available at:

http://www.Asl.milano.it/user/Default.aspx?SEZ=10&PAG=88&NOT=1680 Accessed 9^th april 2014.

25. Arrundale J, Bain M, Botting B, Brewster D, Cartwright R et al. (1997), “Handbook and Guide to the Investigation of Clusters of Diseases”. Leukaemia Research Fund, 43 Great Ormond Street, London, WC1N 3JJ.

26. Drijver M, Melse JM. Disease Clusters and Environmental Contamination I: A Guide for Public Health Services. T Soc Gezondheidsz 1992; 70: 565-570.

27. Fiore B J, Hanrahan LP, Anderson HA. State health department response to disease cluster reports: a protocol for investigation. Am J Epidemiol 1990; 132: S14-22.

28. European surveillance of congenital anomalies. Cluster investigation protocols. [Online]

Available at: http://www.eurocat-

Network.eu/clustersandtrends/clusteradvisoryservice/clusterinvestigationprotocols Accessed on 16^th april 2014

29. Comba P, Bianchi F, Iavarone I, Pirastu R. (Ed.). Impatto sulla salute dei siti inquinati:

metodi e strumenti per la ricerca e le valutazioni. Roma: Istituto Superiore di Sanità;

2007. (Rapporti ISTISAN 07/50).

30. Goodman M, LaKind JS, Fagliano JA et al. Cancer cluster investigations: review of the past and proposal for the future. Int J Environ Res Public Health 2014; 11: 1479-1499.

31. CDC National program of Cancer Registries. [Online] Available at:

http://www.cdc.gov/cancer/npcr/about.htm Accessed on 8^th may 2014.

32. Penberthy L, McClish D, Peace S et al. Hematologic malignancies: an opportunity to fill a gap in cancer surveillance. Cancer Causes Control 2012; 23: 1253–64.

33. Istituto Nazionale di Statistica. Basi Territoriali e variabili censuarie. [Online] Available at:

http://www.istat.it/it/archivio/104317 Accessed on 14^th april 2014.

34. Guidotti TL. Communication models in environmental health. J Health Commun 2013;

18: 1166-79.

35. Bianchi F. Environmental epidemiology and communication in the Taranto crisis.

Epidemiol Prev 2012; 36; 332 – 336.

36. Kramer S, Soskolne CL, Mustapha BA, Al-Delaimy WK. Revised guidelines for environmental epidemiologists. Environ Health Perspect 2012; 120: a299-301.

(4)

37. Pirastu R, Pasetto R, Zona A et al. The health profile of populations living in contaminated sites: SENTIERI approach. J Environ Public Health 2013; 2013:939267.

38. Biggeri A, Lagazio C, Catelan D, Pirastu R, Casson F, Terracini B. Report on health status of residents in areas with industrial, mining or military sites in Sardinia, Italy. Epidemiol Prev 2006; 30 (Suppl 1): 5-95.

39. Alessi D, Pastore G, Baussano I et al. Frequenza e prognosi dei tumori infantili in Piemonte. Il Registro dei Tumori Infantili del Piemonte 1967-2004. CPO, Piemonte. 2006 Torino - Quaderno n° 12.

40. Terracini B. Registri tumori in Italia e loro pertinenza alle aree ad alto rischio ambientale.

In: Istituto Superiore di Sanità, Rapporti ISTISAN 05/1. Indagini epidemiologiche nei siti di interesse nazionale per le bonifiche delle regioni italiane previste dai Fondi strutturali dell’Unione Europea. A cura di Cori L, Cocchi M e Comba P, 2005. 153 p.

41. Biggeri A. Il gruppo di studio ministeriale su Radio Vaticana e il caso del “rospo ostetrico”. Epidemiol prev 2001; 25: 239-244.

42. Rothman KJ. A sobering start for the cluster busters’ conference. Am J Epidemiol 1990;

132: S6–13.

43. Kulldorff M. Tests of spatial randomness adjusted for an inhomogeneity: a general framework. Journal of the American Statistical Association, Vol. 101, No. 475 (Sep., 2006), pp.1289-1305.

44. Hill B. The Environment and Disease: Association or Causation? Proceedings of the Royal Society of Medicine 1965; 58: 295-300.

45. Registro toscano difetti congeniti. Il Registro: che cosa è. [Online] Available at:

http://www.rtdc.it/registro_cosa.htm Accessed on 24^th april 2014

46. International Agency for research on Cancer. Cancer Incidence in five Continents. Vol. IX.

[Online] Available at: http://www.iarc.fr/en/publications/pdfs- online/epi/sp160/CI5vol9.pdf Accessed on 7^th july 2014

47. Regione Toscana. Delibera n. 1200 del 12/12/2005 “Istituto Toscano Tumori - Istituzione Registro Tumori della Regione Toscana”.

48. Autier P, Boniol M. Caution needed for country-specific cancer survival. Lancet 2011;

377(9760): 99-101.

49. Comba P, Fazzo L, Fusco M, Benedetti M, Pirastu R, Ricci P. The contribution of cancer registries in environmental health studies. Epidemiol Prev 2011; 35(5-6 Suppl 4): 189-91.

(5)

50. National Cancer Institute. Surveillance, Epidemiology and End Results (SEER) Program.

[Online] Available at: http://seer.cancer.gov Accessed on 7^th july 2014

51. North American Association of Central Cancer Registries. NAACCR Standards for Cancer Registries. [Online] Available at: http://www.naaccr.org Accessed on 7^th july 2014 52. North American Association of Central Cancer Registries. Certification levels. [Online]

Available at: http://www.naaccr.org/Certification/CertificationLevels.aspx Accessed on 7^th july 2014

53. Filippini G. Epidemiologia descrittiva: possibili fattori causali. In: Sghirlanzoni A, Boiardi A. La terapia dei tumori cerebrali maligni nell’adulto e nel bambino. Milano, Springer- Verlag Italia, 2002.

54. Crocetti E, Buzzoni C, AIRTUM Working Group. Italy is one of the European countries with the greatest population observed by cancer registries. Epidemiol Prev 2010; 34: 82.

55. Remontet L, Mitton N, Couris CM et al. Is it possible to estimate the incidence of breast cancer from medico-administrative databases? Eur J Epidemiol 2008; 23: 681-688.

56. Airtum. La storia. [Online] Available at: http://www.registri-tumori.it/cms/it/storia Accessed on 7^th july 2014

57. Airtum. Mappa dei registri tumori di popolazione [Online] Available at:

http://www.registritumori.it/cms/it/copertura-new Accessed 24^th april 2014.

58. Jensen OM, Parkin DM, Mac Lennan R et al. Cancer Registration, principles and methods.

IARC scientific publications n. 95, Lyon 1991.

59. Airtum. Manuale di tecniche di registrazione dei tumori. 2007, Milano, Inferenze scarl.

[Online] Available at: http://www.registri-tumori.it/cms/?q=Manuale2008 Accessed on 24^th april 2014.

60. Airtum. Qualità dei flussi informativi, metodologie d’integrazione e definizione automatica della casistica nei Registri Tumori. A cura di Sandro Tognazzo, Antonio Russo, Ivan Rashid e il Gruppo di lavoro AIRTUM. [Online] Available at: http://www.registri- tumori.it/cms/FLUSSI2011/home Accessed on 28^thapril 2014.

61. Registro Tumori della Regione Toscana. http://www.registri-tumori.it/cms/RTToscana 62. Zanetti R, Schmidtmann I, Sacchetto L et al. Completeness and timeliness: Cancer

registries could/should improve their performance. Eur J Cancer 2014 Jan 3. doi:

10.1016/j.ejca.2013.11.040. [Epub ahead of print]

(6)

63. Simonato L, Canova C, Corrao G, Costa G, Tessari R et al. Utilizzo epidemiologico di archivi sanitari elettronici correnti. Un’esperienza di standardizzazione delle procedure per la stima di frequenza di alcune malattie in diverse aree italiane. Epidemiol Prev 2008; 32(3) Suppl 1: 1-96.

64. Kush RD, Helton E, Rockhold FW, Hardison CD. Electronic health records, medical research, and the Tower of Babel. N Engl J Med 2008; 358:1738-40.

65. Gini R, Schuemie MJ, Francesconi P, Lapi F, Cricelli I, et al. Can italian healthcare administrative databases be used to compare regions with respect to compliance with standards of care for chronic diseases? PLoS ONE 2014; 9(5): e95419.

doi:10.1371/journal.pone.0095419

66. Gavrielov-Yusim N, Friger M. Use of administrative medical databases in population- based research. J Epidemiol Community Health 2013; 10.1136/jech-2013-202744.

67. Istituto Superiore di Sanità. L’integrazione di archivi elettronici per l’epidemiologia e la sanità pubblica: finalità e metodi. Istituto Superiore di Sanità, Roma, 17-18 maggio 2007.

Riassunti. A cura di Eva Appelgren e Paola Luzi 2007, x, 61 p. ISTISAN Congressi 07/C2 Available at: www.iss.it

68. Brameld KJ, Holman CD, Lawrence DM, Hobbs MS. Improved methods for estimating incidence from linked hospital morbidity data. International journal of Epidemiol 2003;

32: 617-624.

69. Programma Nazionale Valutazione Esiti. Fonti informative e criteri di record linkage.

[Online] Available at: http://95.110.213.190/PNEed13/fonti-informative.php Accessed on 4^th july 2014.

70. Baldi I, Vicari P, Di Cuonzo D, et al. A high positive predictive value algorithm using hospital administrative data identified incident cancer cases. J Clin Epidemiol 2008; 6:

373-9.

71. Lonati F, Scarcella C, Indelicato A et al. La Banca dati assistito di Brescia: una metodologia basata su dati correnti per il monitoraggio delle patologie croniche e per la gestione delle risorse. Epidemiol Prev 2008; 32: 137-44.

72. Vassallo F, Lonati F, Cecchi D et al. La presa in carico dei malati cronici nell’ASL di Brescia: monitoraggio BDA 2003-2006. Asl Brescia, 2008. Available at:

http://www.Aslbrescia.it/media/pdf/pubblicazioni/malati_cronici_2009.pdf Accessed on 4^th may 2014.

(7)

73. Gnavi R, Karaghiosoff L, Balzi D et al. Stima della prevalenza di diabete basata su dati sanitari correnti mediante un algoritmo comune in differenti aree italiane. Epidemiol Prev 2008; 32(3) Suppl 1: 15-21.

74. Ganry O, Taleb A, Peng J, Ravedy N, Dubreuil A. Evaluation of an algorithm to identify incident breast cancer cases using DRGs data. Eur J Cancer Prev 2003; 12; 295-99.

75. Goldberg DS, Lewis JD, Halpern SD, Weiner MG, Lo Re V 3rd. Validation of a coding algorithm to identify patients with hepatocellular carcinoma in an administrative database. Pharmacoepidemiol Drug Saf 2013; 22: 103-7.

76. Rosso S, Zanetti R. Le potenzialità degli archivi SDO per gli studi epidemiologici.

Epidemiol Prev 2009; 33: 146.

77. Ferretti S, Guzzinati S, Zambon P et al. Stima dell’incidenza del carcinoma mammario attraverso il flusso dei ricoveri ospedalieri: confronto con i dati dei registri tumori.

Epidemiol Prev 2009; 33: 147-53.

78. Pirastu R, Comba P, Conti S et al. Gruppo di Lavoro Sentieri. SENTIERI: Mortalità, incidenza oncologica e ricoveri ospedalieri. Epidemiol Prev 2014; 38 (2), suppl. 1, pp 1- 170.

79. Gold HT, Do HT. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data. Health Serv Res 2007; 42: 2056-69.

80. Mitton N, Colonna M, Trombert B et al. A Suitable Approach to Estimate Cancer Incidence in Area without Cancer Registry. J Cancer Epidemiol 2011; 2011: 418968.

81. Tessari R, Canova C, Canal F et al. Indagine su inquinamento ambientale da diossine e sarcomi dei tessuti molli nella popolazione di Venezia e Mestre: un esempio di utilizzo di fonti informative elettroniche correnti. Epidemiol Prev 2006; 30(3): 191-98.

82. Scurti V, Di Ienno S, Fanizza C et al. Hospital discharge database as a tool to monitor incidence, survival and burden of cancer in adolescents and young adults. Tumori 2012;

98: 19-26.

83. Provincia di Pisa. Rapporto sullo stato dell’ambiente. Agenda 21, comprensorio del cuoio. Pisa, ed. Pacini, 2002.

84. Iaia TE, Bartoli D, Calzoni P, Comba P et al. Studio di coorte di mortalità degli addetti alla concia del cuoio e delle pelli nel territorio dell'azienda USL 11 - Zona Valdarno Inferiore.

La Medicina del lavoro 2002; 93(2): 95-107.

85. Gluzman DF. WHO classification of lymphoid malignancies. Exp Oncol 2012; 34(4): 377-8.

(8)

86. Vardiman JW. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms. Chem Biol Interact 2010; 184(1-2): 16-20.

87. International Myeloma Working Group. Criteria for the classification of monoclonal gammopaties, multiple myeloma and related disorders: a report of the International Myeloma Workig Group. Br J Haematol 2003; 121: 749-57.

88. Agence française de sécurité sanitaire de l’environnement et du travail (Afsset). Cancer et environnement. Expertise collective. Paris, ed. Inserm, 2008.

89. Ezoe S. Secondary leukemia associated with the anti-cancer agent, etoposide, a topoisomerase II inhibitor. Int J Environ Res Public Health 2012; 9(7): 2444-53.

90. McNally RJ, Parker L. Environmental factors and childhood acute leukemias and lymphomas. Leuk Lymphoma 2006; 47(4): 583-98.

91. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 100D.

Radiation. Lyon, IARC, 2009a.

92. World Health Organization, 2007. Extremely low frequency fields. Geneva. Environ Health Criteria n. 238.

93. Wertheimer N, Leeper E. Electrical wiring configurations and childhood cancer. Am J Epidemiol 1979; 109: 273–84.

94. Teepen C and van Dijck AAM, Impact of high electromagnetic field levels on childhood leukaemia incidence. Int J Cancer 2012; 131: 769-778.

95. International Agency for Research on Cancer, 2002. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol.80: Non - ionizing radiation, Part 1. Static and extremely low frequency (ELF) electric and magnetic fields. W.H.O./I.A.R.C. Lyon, France.

96. Ahlbom A, Day N, Feychting M et al. A pooled analysis of magnetic fields and childhood leukaemia. Br J Cancer 2000; 83: 692-8.

97. Greenland S, Sheppard AR, Kaune WT, Poole C, Kelsh MA. A pooled analysis of magnetic fields, wire codes, and childhood leukemia. Childhood Leukemia-EMF Study Group.

Epidemiology 2000; 11: 624-34.

98. Kheifets L et Al. Pooled analysis of recent studies on magnetic fields and childhood leukaemia. Br J Cancer 2010; 103: 1128-35.

(9)

99. Agenzia Regionale per la Prevenzione e Protezione Ambientale del Veneto. Glossario dei rischi ambientali. [Online] Available at:

http://www.arpa.veneto.it/glossario_amb/htm/benzene.asp Accessed on 8th july 2014.

100. IARC monographs on the evaluation of carcinogenic risks to humans ; v. 100F. A review of human carcinogens. Part F: Chemical agents and related occupations / IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. 2009: Lyon, France.

101. Savitz DA, Andrews KW. Review of epidemiologic evidence on benzene and lymphatic and hematopoietic cancers. Am J Ind Med 1997; 31(3):287-95.

102. Agenzia Regionale per la Protezione Ambientale Toscana. I gas di scarico dei motori diesel nella lista delle sostanze cancerogene certe. [Online] Available at:

http://www.arpat.toscana.it/notizie/notizie-brevi/2012/i-gas-di-scarico-dei-motori- diesel-nella-lista-delle-sostanze-cancerogene Accessed on 19th may 2014.

103. Benbrahim-Tallaa L, Baan RA, Grosse Y et al; International Agency for Research on Cancer Monograph Working Group. Carcinogenicity of diesel-engine and gasoline-engine exhausts and some nitroarenes. Lancet Oncol 2012; 13(7): 663-4.

104. Amigou A, Sermage-Faure C, Orsi L, et al. Road traffic and childhood leukemia: the ESCALE study (SFCE). Environ Health Perspect 2011; 119(4): 566-72.

105. Badaloni C, Ranucci A, Cesaroni G, et al. Air pollution and childhood leukaemia: a nationwide case-control study in Italy. Occup Environ Med 2013; 70(12): 876-83.

106. Boothe VL, Boehmer TK, Wendel AM, Yip FY. Residential traffic exposure and childhood leukemia: a systematic review and meta-analysis. Am J Prev Med 2014; 46(4): 413-22.

107. Istituto Superiore per la Protezione e la Ricerca Ambientale. Rapporto nazionale pesticidi nelle acque. Rapporti 175/2013. 2013, ISPRA. ISBN 978-88-448-0595-1

108. ISTAT. Annuario statistico italiano 2013. [Online] Available at:

http://www.istat.it/it/archivio/107568 Accessed on 19th may 2014.

109. Miligi L, Seniori Costantini A, Veraldi A et al. Cancer and pesticides. An overview and some results of the Italian multicenter case–control study on hematolymphopoietic malignancies. Ann N.Y. Acad Sci 2006; 1076: 366–377.

110. Alavanja Mc, Ross Mk, Bonner Mr. Increased cancer burden among pesticide applicators and others due to pesticide exposure. Ca Cancer J Clin 2013; 63: 120-42.

111. Miligi L. Studi epidemiologici in agricoltura e nel florovivaismo: inquadramento generale.

Convegno Regionale 23 - 24 Ottobre 2008, Regione Toscana. [Online] Available at:

http://www.usl3.toscana.it/Sezione.jsp?idSezione=2252 Accessed on 8^th July 2014.

(10)

112. Pisani P, Parodi S, Magnani C. Causes And Risk Factors For Childhood Cancer. Epidemiol Prev 2013; 37(1 Suppl 1): 234-54.

113. Turner MC, Wigle DT, Krewski D. Residential pesticides and childhood leukemia: a systematic review and meta-analysis. Environ Health Perspect 2010; 118(1): 33-41.

114. Caranci N, Biggeri A, Grisotto L et al. The Italian deprivation index at census block level:

definition, description and association with general mortality. Epidemiol Prev 2010;

34(4): 167-76.

115. Virnig BA, McBean M. Administrative data for public health surveillance and planning.

Annu Rev Public Health 2001; 22: 213-30.

116. McBean AM, Gornick M. Differences by race in the rates of procedures performed in hospitals for Medicare beneficiaries. Health Care Financ Rev 1994; 15(4): 77-90.

117. Wennberg JE, Cooper MM, eds. The Dartmouth Atlas of Health Care in the United States. 1996, Chicago: Am Hosp Publ.

118. Programma Nazionale Esiti – Introduzione alla lettura. [Online] Avalilable at:

http://95.110.213.190/PNEed13/introduzione-alla-lettura.pdf Accessed on 4^th july 2014.

119. Riley GF. Administrative and claims records as sources of health care cost data. Med Care 2009; 47(7 Suppl 1): S51-5.

120. Craig BM, Rollison DE, List AF, Cogle CR. Underreporting of myeloid malignancies by United States cancer registries. Cancer Epidemiol Biomarkers Prev 2012; 21: 474-481.

121. Cogle CR. Fishing for myelodysplastic syndromes finds uncaptured cases by state cancer registries: Need for more resources. Cancer 2014 Mar 18. doi: 10.1002/cncr.28638.

122. Zent CS, Kyasa MJ, Evans R, Schichman SA. Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data. Cancer 2001 ;92:1325-30.

123. Setoguchi S, Solomon DH, Glynn RJ, Cook EF, Levin R, Schneeweiss S. Agreement of diagnosis and its date for hematologic malignancies and solid tumors between medicare claims and cancer registry data. Cancer Causes Control 2007; 18(5): 561-9.

124. Herman RA, Gilchrist B, Link BK, Carnahan R. A systematic review of validated methods for identifying lymphoma using administrative data. Pharmacoepidemiol Drug Saf 2012;

21 Suppl 1:203-12.

125. Redaelli A, Laskin BL, Stephens JM, Botteman MF, Pashos CL. The clinical and epidemiological burden of chronic lymphocytic leukaemia. Eur J Cancer Care (Engl) 2004;

13: 279-87.

(11)

126. Airtum Working Group; CCM; AIEOP Working Group. Italian cancer figures, report 2012:

Cancer in children and adolescents. Epidemiol Prev 2013; 37(1 Suppl 1): 1-225.

127. Belpomme D, Irigaray P, Hardell L, Clapp R, Montagnier L, Epstein S, Sasco AJ. The multitude and diversity of environmental carcinogens. Environ Res 2007; 105(3): 414- 429.

128. Associazione italiana di oncologia medica (AIOM). Progetto ambiente e tumori., 2011, Longone al Segrino, ed. Grafismi.

129. World Health Organization. Environmental Health Criteria 237. Principles for evaluating health risks in children associated with exposure to chemicals. Geneva, World Health Organization, 2007

130. World Health Organization. Summary of Principles for Evaluating Health Risks in Children Associated with Exposure to Chemicals. Geneva, World Health Organization, 2011.

131. Iavarone I, Pirastu R, Minelli G, Comba P. Children's health in Italian polluted sites.

Epidemiol Prev 2013; 37(1 Suppl 1): 255-60.

132. Association of Faculties of Medicine of Canada. AFMC Primer on Population Health. A virtual textbook on Public Health concepts for clinicians. [Online] Available at:

http://phprimer.afmc.ca/inner/primer_contents Accessed 9^th april 2014.

133. Last JM. A Dictionary of Epidemiology. Oxford University Press/International Epidemiological Association, New York 2001.

134. Martuzzi M, Thickner J et al . The precautionary principle: protecting public health, the environment and the future of our children. WHO Regional Office for Europe, Copenhagen, 2004.

135. Forastiere F, Ancona C, Davoli M. Quale valutazione epidemiologica per i siti inquinati in Italia? Epidemiol Prev 2014; 38: 1-1.

136. Saracci R. Epidemiologia, “liasones dangereuses” e Sanità Pubblica. Epidemiol Prev 2014;

38(2): 133-137.